Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism EP1 antagonists(Prostanoid EP1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-erosive gastro-esophageal reflux disease | Phase 2 | United Kingdom | 01 Dec 2012 | |
Urinary Bladder, Overactive | Phase 2 | Germany | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Ukraine | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Russia | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Hungary | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Romania | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Czechia | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Poland | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Netherlands | 01 Apr 2009 | |
Urinary Bladder, Overactive | Phase 2 | Sweden | 01 Apr 2009 |